Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 1
1967 1
1968 2
1969 2
1977 1
1979 1
1980 3
1983 1
1984 1
1987 3
1989 1
1990 4
1991 10
1992 2
1993 1
1994 2
1995 7
1996 3
1997 6
1998 6
1999 3
2000 4
2001 8
2002 5
2003 3
2004 4
2005 5
2006 9
2007 8
2008 14
2009 7
2010 10
2011 9
2012 11
2013 14
2014 12
2015 9
2016 16
2017 14
2018 11
2019 16
2020 17
2021 7
2022 7
2023 12
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

266 results

Results by year

Filters applied: . Clear all
Page 1
Osimertinib in Patients With Epidermal Growth Factor Receptor Mutation-Positive Non-Small-Cell Lung Cancer and Leptomeningeal Metastases: The BLOOM Study.
Yang JCH, Kim SW, Kim DW, Lee JS, Cho BC, Ahn JS, Lee DH, Kim TM, Goldman JW, Natale RB, Brown AP, Collins B, Chmielecki J, Vishwanathan K, Mendoza-Naranjo A, Ahn MJ. Yang JCH, et al. Among authors: brown ap. J Clin Oncol. 2020 Feb 20;38(6):538-547. doi: 10.1200/JCO.19.00457. Epub 2019 Dec 6. J Clin Oncol. 2020. PMID: 31809241 Free PMC article. Clinical Trial.
Patch clamp.
Brown AP, Greenberg HZ. Brown AP, et al. Br J Hosp Med (Lond). 2016 May;77(5):C74-7. doi: 10.12968/hmed.2016.77.5.C74. Br J Hosp Med (Lond). 2016. PMID: 27166119 Review. No abstract available.
CNS Response to Osimertinib Versus Standard Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients With Untreated EGFR-Mutated Advanced Non-Small-Cell Lung Cancer.
Reungwetwattana T, Nakagawa K, Cho BC, Cobo M, Cho EK, Bertolini A, Bohnet S, Zhou C, Lee KH, Nogami N, Okamoto I, Leighl N, Hodge R, McKeown A, Brown AP, Rukazenkov Y, Ramalingam SS, Vansteenkiste J. Reungwetwattana T, et al. Among authors: brown ap. J Clin Oncol. 2018 Aug 28:JCO2018783118. doi: 10.1200/JCO.2018.78.3118. Online ahead of print. J Clin Oncol. 2018. PMID: 30153097 Free article.
Confounding experimental considerations in nanogenotoxicology.
Doak SH, Griffiths SM, Manshian B, Singh N, Williams PM, Brown AP, Jenkins GJ. Doak SH, et al. Among authors: brown ap. Mutagenesis. 2009 Jul;24(4):285-93. doi: 10.1093/mutage/gep010. Epub 2009 Apr 7. Mutagenesis. 2009. PMID: 19351890 Free article. Review.
Ubiquitin is a carbon dioxide-binding protein.
Linthwaite VL, Pawloski W, Pegg HB, Townsend PD, Thomas MJ, So VKH, Brown AP, Hodgson DRW, Lorimer GH, Fushman D, Cann MJ. Linthwaite VL, et al. Among authors: brown ap. Sci Adv. 2021 Sep 24;7(39):eabi5507. doi: 10.1126/sciadv.abi5507. Epub 2021 Sep 24. Sci Adv. 2021. PMID: 34559559 Free PMC article.
266 results